Indication Selection
Discover and evaluate novel indications for your target of interest by the unique combination of Euretos computational disease models and direct access to the Euretos AI Platform.
Accelerate and de-risk indication selection
We work closely with many pharmaceutical & biotech companies to accelerate and de-risk their indication selection process. Take a biomolecular data-driven approach and empower your domain experts to evaluate results and draw their own, evidence based conclusions!
Data-driven, novel indication candidates
We support purchasing via scientist.com and science exchange!
Minimise literature bias in indication discovery
Empower your domain experts to evaluate indication predictions
Tailored to your situation
A collaborative research approach
Find out how Euretos helped find novel indications in rare diseases. Submit the below form and get the case study:
Read our Terms and Conditions
Keep up with our latest news and events. Sign up for our newsletter.